CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for LBC Bioscience Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

LBC Bioscience Inc
10855 N 116th Street
Suite 115
Phone: 480-326-8577p:480-326-8577 Scottsdale, AZ  85258  United States
This company was Merged or Acquired on 1/9/2019.
This is a Subsidiary, click here for the Parent Company
Business Summary
LBC Bioscience Inc. is engaged in the cannabidiol (CBD) market. The Company’s primary focus is on developing and marketing organic products, such as CBD water, drops, edibles, pet supplements, recovery balm and spray. Its product categories include CBD hemp oil herbal drops, CBD pet treats, CBD pet drops, and CBD hemp rub. The Company’s Pet Hemp CBD Treats is made up of rice bran, cane molasses, rice flour, water, tapioca starch, cheese flavor, lecithin, safflower oil, glycerin, passion flower, valerian root, ginger root, ascorbic acid, sorbic acid, calcium propionate, CBD hemp oil, and vitamin E. Its Hemp CBD Pet Drops contains rich hemp oil, glucosamine, chondroitin, hyaluronic acid, aloe vera gel, fructose, natural flavor, and organic glycerin.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201712/31/2016YesYes---

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
CEO, CFO & Director LisaNelson
Chairman of the Board, President Lisa A.Nelson 50
Chief Operating Officer, Secretary, Director FrankParella 60
Chief Operating Officer FrankPerella

General Information
Number of Employees: 3 (As of 6/30/2017)
Outstanding Shares: 36,264,000 (As of 6/30/2017)
Federal Tax Id: 474916852


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023